Bay Area's SutroVax Scores $64 Million To Tackle Pneumococcal Vaccines - BioLegacy Research

Bay Area's SutroVax Scores $64 Million To Tackle Pneumococcal Vaccines

Post author:Sam
Post published:March 20, 2017
Post category:BioPharma

Life Sciences Jobs …
Source: BioSpace